Actionable news
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

J.P. Morgan Weighs in on Regeneron Pharmaceuticals Inc (REGN) Following Sarilumab CRL

J.P. Morgan analyst Cory Kasimov was out today with a few insights on Regeneron Pharmaceuticals Inc (NASDAQ:REGN), after the drug maker announced, along with its partner Sanofi (NYSE:SNY), the receipt of a complete response letter (CRL) from the FDA for sarilumab, the company’s IL-6R antibody for the treatment of rheumatoid arthritis.

Kasimov noted, “While this is certainly a negative headline, we consider it to be somewhat anti-climactic following Sanofi’s disclosure this morning—in conjunction with its 3Q report—that the FDA identified manufacturing deficiencies at a...